[go: up one dir, main page]

WO1997032593A3 - Composition contenant des iso-flavonoides et des lignanes - Google Patents

Composition contenant des iso-flavonoides et des lignanes Download PDF

Info

Publication number
WO1997032593A3
WO1997032593A3 PCT/GB1997/000622 GB9700622W WO9732593A3 WO 1997032593 A3 WO1997032593 A3 WO 1997032593A3 GB 9700622 W GB9700622 W GB 9700622W WO 9732593 A3 WO9732593 A3 WO 9732593A3
Authority
WO
WIPO (PCT)
Prior art keywords
lignans
flavonoids
composition
component
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1997/000622
Other languages
English (en)
Other versions
WO1997032593A2 (fr
Inventor
Michael Stafford Morton
Keith Griffiths
Carl Herman Thoma Adler-Creutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Energiser PLC
Original Assignee
Energiser PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604945.7A external-priority patent/GB9604945D0/en
Priority claimed from GBGB9610768.5A external-priority patent/GB9610768D0/en
Application filed by Energiser PLC filed Critical Energiser PLC
Priority to AU21009/97A priority Critical patent/AU2100997A/en
Publication of WO1997032593A2 publication Critical patent/WO1997032593A2/fr
Publication of WO1997032593A3 publication Critical patent/WO1997032593A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36—Vegetable material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/55—Linaceae (Flax family), e.g. Linum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention porte sur une composition et une méthode de traitement servant à combattre certains états morbides, tels que le cancer et spécialement avant que lesdits états ne soient cliniquement détectables, ou alors à un stade peu avancé. Ladite composition a le pouvoir d'élever les niveaux d'iso-flavonoïdes (par exemple la génistéine) et de lignanes (par exemple des entérolactones) du corps à des niveaux d'efficacité thérapeutique. Ladite composition qui se présente sous forme d'aliment sous la forme pratique d'un biscuit ou d'un petit gâteau, comporte un constituant de soja, associé à un constituant de graine de lin, et/ou à un constituant de seigle.
PCT/GB1997/000622 1996-03-08 1997-03-10 Composition contenant des iso-flavonoides et des lignanes Ceased WO1997032593A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU21009/97A AU2100997A (en) 1996-03-08 1997-03-10 Composition containing iso-flavonoids and lignans

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9604945.7 1996-03-08
GBGB9604945.7A GB9604945D0 (en) 1996-03-08 1996-03-08 Composition
GB9610768.5 1996-05-23
GBGB9610768.5A GB9610768D0 (en) 1996-05-23 1996-05-23 Composition

Publications (2)

Publication Number Publication Date
WO1997032593A2 WO1997032593A2 (fr) 1997-09-12
WO1997032593A3 true WO1997032593A3 (fr) 1997-10-30

Family

ID=26308892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/000622 Ceased WO1997032593A2 (fr) 1996-03-08 1997-03-10 Composition contenant des iso-flavonoides et des lignanes

Country Status (2)

Country Link
AU (1) AU2100997A (fr)
WO (1) WO1997032593A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261565B1 (en) 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US6391310B1 (en) 1996-03-13 2002-05-21 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of neurological symptoms
EP0954984A1 (fr) * 1998-05-04 1999-11-10 Källna Specialprodukter AB Composition diététique contenant des fibres
US6689809B2 (en) 1999-03-30 2004-02-10 Hormos Nutraceutical Oy Ltd. Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol
US6451849B1 (en) 1999-03-30 2002-09-17 Hormos Nutraceutical Oy Ltd. Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol
FI115192B (fi) * 2001-02-26 2005-03-31 Oriola Oy Funktionaalinen elintarvike ja sen valmistusmenetelmä
FI120901B (fi) * 2004-08-25 2010-04-30 Oriola Oy Funktionaalinen elintarvike ja sen käyttö
US20080057140A1 (en) * 2005-01-10 2008-03-06 Mikko Unkila Use of a Lignan for the Manufacture of a Composition for Preventing or Alleviating of Symptoms Relating to Estrogen Deficiency
ITPI20110034A1 (it) 2011-04-01 2012-10-02 Funcional Food Res S R L Preparazione alimentare funzionale ad uso femminile.
CN108208076A (zh) * 2018-01-09 2018-06-29 广州聚澜健康产业研究院有限公司 一种巧克力舒芙蕾及其制备方法
KR20230055262A (ko) * 2021-10-18 2023-04-25 리누 바이오 헬스 엘티디. 파이토젠을 유효성분으로 포함하는 여성갱년기 질환 예방 및 치료용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4001905A1 (de) * 1990-01-24 1991-07-25 Wilhelm Menge Verfahren zum herstellen einer backware

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4001905A1 (de) * 1990-01-24 1991-07-25 Wilhelm Menge Verfahren zum herstellen einer backware

Also Published As

Publication number Publication date
WO1997032593A2 (fr) 1997-09-12
AU2100997A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
EP1273298A3 (fr) Ritonavir en combinaison avec un inhibiteur de la protéase du VIH additionnel pour le traitement du SIDA
WO1996005838A3 (fr) Preparation combinee pour le traitement de maladies immunitaires
WO2002056912A3 (fr) Methode de traitement du cancer
CA2301057A1 (fr) Procede permettant d'administrer un taxane liposomal encapsule
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
EP1040827A3 (fr) Utilisation de 3,4-dihydroxy-2-hydroxyméthylepyrrolidine pour le traitement du diabète
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
AU3074289A (en) 2,2'-iminobisethanol derivatives as potentiators of the effects of blood pressure reducing agents
WO1997032593A3 (fr) Composition contenant des iso-flavonoides et des lignanes
CA2373794A1 (fr) Compositions et utilisation d'et743 pour le traitement du cancer
WO1998001440A3 (fr) Compositions pharmaceutiques antivirales contenant des composes 1,2-dithiaheterocycliques satures et utilisation de ces compositions
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
CA2019812A1 (fr) Nouveau 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-ones et leur utilisation dans la prevention et le traitement du sida
CA2412789A1 (fr) Compositions destinees a ameliorer la concentration mentale
AU2001287850A1 (en) Iron compositions
CA2152771A1 (fr) Derives 7-o-ether de taxane
WO1996041627A3 (fr) Composes de fer, compositions et procedes de fabrication de ces composes et leurs utilisations
WO2003045324A3 (fr) 14-methyl-epothilones
CA2152998A1 (fr) Composition pharmaceutique anti-hyperglycemique
CA2270423A1 (fr) Agent prophylactique/therapeutique
WO1996021468A3 (fr) Interferent chimiquement modifie
CA2063273A1 (fr) Surfactants pulmonaires et methodes
CA2014885A1 (fr) 6,11-dihydro-5h-pyrido[2,3-b] [1,5] benzodiazepin-5-ones et thiones et leur utilisation dans la prevention et le traitement du sida

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1997906264

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWW Wipo information: withdrawn in national office

Ref document number: 1997906264

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97531581

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase